A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women

Clinical trial NCT06983925 · COMPLETED

Trial details

NCT number: NCT06983925
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Postmenopausal Women

Start date: 2025-04-30
Primary completion: 2025-07-14
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.